Celera leads drug stocks in Friday gains
March 18, 2011 at 10:58 AM EDT
Gains in the genomics company’s stock push past the $8-a-share offer announced by Quest Diagnostics.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|